Technical Articles

DKK-1能否成为成骨不全症的新型治疗靶点?
Can DKK-1 Become a Novel Therapeutic Target for Osteogenesis Imperfecta?
发布时间 2025-09-18
Osteogenesis Imperfecta (OI), also known as brittle bone disease, is a rare genetic connective tissue disorder with an incidence of approximately 1/10,000 to 1/20,000. Patients often present with low bone mass, increased bone fragility, recurrent fractures, and may exhibit extra-skeletal manifestations such as blue sclerae, hearing loss, and dentinogenesis imperfecta.
View details
  • Stem Cells
  • Osteogenesis Imperfecta
  • DKK-1
  • Genetic Disorder
Total 1
  • 1
Go to